azacitidine has been researched along with lactoferrin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H; Peng, D; Ren, CP; Wang, L; Yao, KT; Yi, HM; Zhang, HJ; Zhao, M | 1 |
| Li, YC; Yi, HM; Zhong, RH | 1 |
| Cheng, H; Hu, X; Huang, C; Liu, J; Tang, G; Wang, J; Yang, J; Zhou, H | 1 |
3 other study(ies) available for azacitidine and lactoferrin
| Article | Year |
|---|---|
Genetic and epigenetic alterations of LTF at 3p21.3 in nasopharyngeal carcinoma.
Topics: Azacitidine; Base Sequence; Carcinoma; Cell Line, Tumor; Chromosomes, Human, Pair 3; CpG Islands; Decitabine; DNA Methylation; DNA Modification Methylases; DNA Mutational Analysis; Down-Regulation; Enzyme Inhibitors; Epigenesis, Genetic; Exons; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Lactoferrin; Loss of Heterozygosity; Male; Middle Aged; Molecular Sequence Data; Mutation; Nasopharyngeal Neoplasms; Polymorphism, Single-Stranded Conformational; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2006 |
[Expression, genetic and epigenetic alterations of LTF gene in nasopharyngeal carcinoma cell lines].
Topics: Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Tumor; Decitabine; DNA Methylation; Epigenesis, Genetic; Gene Deletion; Humans; Lactoferrin; Loss of Heterozygosity; Nasopharyngeal Neoplasms; Nasopharyngitis; Promoter Regions, Genetic; RNA, Messenger | 2010 |
[Effects of decitabine against acute T lymphoblastic leukemia cell line Molt4].
Topics: Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Decitabine; DNA Methylation; Humans; Lactoferrin; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Promoter Regions, Genetic | 2015 |